refine this therapy and subsequently achieve high efficiency, novel nanomaterials can be designed and modified either to enhance the uptake and drug delivery to the cancer site, or control treatment
laser attenuation. PS was found to significantly improve magnetite nanoparticle stability in modified Hank’s Balanced Salt Solution, serum containing media, reduces innate toxicity over 48 hours compared to uncoated
respond to the demands of life.” The PAP of each individual is the most modifi-able component of the model. It responds positively to constructive social interactions and to personal
genetic information of a particular organism. The technology allows the production of genetically modified organism (GMO) that has the enhanced property compared to the unmodified organism. The application
plasma power on extent of surface modification. Plasma treatment was used to modify the implant surface to facilitate the adhesion of antimicrobial drug. Surface topography of the implanted material
that advance oxygen processes were efficient for P release into treated supernatant. The synthesis modified biochar was used to high selectivety recover P from the treated supernatant. The P adsorption ... modified…
only lead to undeniable both socio-economic and environmental benefits. Activated carbon (AC) and modified AC were tested as solid sorbents at the purpose. The modified AC was synthesized ... estimated by COD analysis…
present the results on the preparation and use of a series of novel modified DTPA-based ligands grafted onto TiO2 nanoparticles in order to provide a better understanding
feasibility of using scrap polyurethane foam (PUF) and ground tire rubber (GTR) separately. The modified asphalt blend samples were initially prepared in a molten state: in one time as singular ... added to the asphalt…
have been found mainly in plants of the families Meliaceae, Rutaceae, and Simaroubaceae, are modified triterpene derivatives originating from a precursor with a 4,4,8-trimethyl-17-furanylsteroid skeleton
also an essential disinfection procedure for virus elimination from contaminated surfaces. The cleaning by modified wipes containing antiviral compounds is also of major interest. The present work reports the…
degree of persistent aneurysm or neck filling and is often classified by the ‘modified Montreal’ or ‘Raymond’ system. A better immediate angiographic result is shown to reduce aneurysm recurrence. Immediate
numerous agents over a wide array of mechanisms including neurotransmitter modulation and disease modifying therapy targeting amyloid and tau. The failures of clinical trials ... design of upcoming trials, especially as…
interventions other than glucose and blood pressure control that have reliably been shown to modify albuminuria and alter the course of diabetic nephropathy. This review highlights recently completed and ongoing
cost, confirmatory Phase III trials. In adaptive design trials – which use early findings to modify the trial toward the most promising dose, sample size or patient population – simulation is instrumental
Decades of experimental research are yet to lead to the development of effective disease-modifying interventions. The limitations of in vivo research in AD are currently poorly understood
receptor agonist developed for the treatment of Type 2 diabetes. It consists of two modified ‘GLP-1’ moieties covalently linked to a human immunoglobulin (IgG) 4-FC heavy chain
Glucosamine sulfate is, so far, the only drug that has demonstrated a combined symptom-modifying and potential structure-modifying effect in knee osteoarthritis when used as the prescription crystalline glucosamine
Relevant studies in which compounds/agents have been tested for potential effect as disease-modifying OA drugs in large-to-small OA animal models are reviewed. Special attention is given ... means comprehensive, but…
unknown. This article explores how bone and, in particular, the subchondral bone tissue is modified in OA, and which mechanisms could be responsible for the alterations observed
This article examines biologics as emerging therapies for osteoarthritis. There are currently no disease‑modifying antiosteoarthritis drugs. IL‑1b and TNF‑a are two major cytokines produced by the synovial
cystic fibrosis, as well as some of the challenges associated with finding disease-modifying therapies. In this article we give a brief description of the clinical and epidemiological aspects ... pathophysiology of…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.